Issue Brief
Fixing the Funnel: Stakeholder Insights on Alzheimer’s Disease Trial Recruitment
August 7, 2026
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Mireille Jacobson, PhD, Desi Peneva, MS
Research
All Research Featured Research
Comment Letter
Comments on FDA’s Proposed Expedited Investigational New Drug Pilot Program
July 28, 2026
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
Alzheimer’s Drugs Deserve a Second Opinion
July 13, 2026
Featured Experts: Paul Aisen, MD, Joseph Grogan, JD
Comment Letter
Comments on Cures in Care Initiative
June 30, 2026
Featured Experts: Mireille Jacobson, PhD, Sidra Haye, PhD, Phyllis Barkman Ferrell, DrPH, MBA, Dana Goldman, PhD, Barry Liden, JD
Perspective
Improving Clinical Trials Reporting in Medicare Claims
June 12, 2026
Featured Experts: Sidra Haye, PhD, Mireille Jacobson, PhD
Comment Letter
Comments on the Commissioner’s National Priority Voucher Pilot Program
June 4, 2026
Featured Experts: Lowell Schiller, JD
Evidence Base
Alzheimer’s Biomarkers May Vary Across Populations—Complicating Trial Eligibility
May 21, 2026
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA
Perspective
Why Widespread Testing for Alzheimer’s Is Essential
April 6, 2026
Featured Experts: Dana Goldman, PhD
White Paper
High-Stakes Medicine: Rethinking Policies for the Cost and Value of Cell and Gene Therapies
March 19, 2026
Featured Experts: Alison Sexton Ward, PhD, Elizabeth Fowler, PhD, JD, Jeremy L. Shane, Darius Lakdawalla, PhD
Evidence Base
What Nearly 1,000 Studies Reveal About Alzheimer’s Clinical Trial Recruitment
March 18, 2026
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA
Journal Article
Evaluating Evidence-Based Recruitment Strategies for Alzheimer’s Disease and Related Dementias Clinical Trial Research: A Literature Review
March 16, 2026
Featured Experts: Mireille Jacobson, PhD, Desi Peneva, MS, Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Rema Raman, PhD, Paul Aisen, MD, Dana Goldman, PhD
News
Can We Prevent Alzheimer’s Disease Within a Decade?
March 5, 2026
Featured Experts: Paul Aisen, MD, Dana Goldman, PhD
News
USC Initiative Awards Funding to Test AI-Driven Strategies to Accelerate Alzheimer’s Clinical Trials
January 20, 2026
Featured Experts: Dana Goldman, PhD, Paul Aisen, MD
Testimony
Testimony on Accelerating Medical Breakthroughs for American Patients and Their Families
December 9, 2025
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Current Evidence of Randomized Clinical Trials on Hospice-Eligible Patients With Agitation and Dementia: A Narrative Review
November 27, 2025
Featured Experts: Doris Molina-Henry, PhD, Rema Raman, PhD
Testimony
Testimony on Maintaining U.S. Biotech Competitiveness and Delivering Lifesaving Cures to Patients
October 29, 2025
Featured Experts: Lowell Schiller, JD
Journal Article
Recruitment and Retention in a Preclinical AD Trial: Comparisons Between Academic and Non-Academic Sites
October 14, 2025
Featured Experts: Marina Ritchie, PhD, Paul Aisen, MD, Rema Raman, PhD
News
Former FDA Leaders Say New Policies Needed to Boost Medical Innovation
September 26, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD
News
Schaeffer Center White Paper Outlines FDA Reforms to Boost Pharmaceutical Innovation and Expand Access
September 11, 2025
Featured Experts: Lowell Schiller, JD, Barry Liden, JD